Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactobacillus and glutamine for aspirin-induced small intestinal mucosal injury
ChiCTR2100049835Phase 4Not yet recruiting
- Sponsor
- Beijing An Zhen Hospital
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of glutamine in aspirin-induced enteropathy (4 arms), sponsored by Beijing An Zhen Hospital. Primary endpoint: Small intestinal mucosal injury level. Planned start Sep 2021; status: not yet recruiting.
02
Drugs
glutamine
03
Conditions
aspirin-induced enteropathy
Beyond the preview
Go deeper on ChiCTR2100049835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100049835.